Concentrix CEO disposes 2,591 shares at $41.61

Concentrix Corp President and CEO Christopher A. Caldwell reported a disposition of company common stock.

Rhea-AI Filing Summary

Concentrix Corp President and CEO Christopher A. Caldwell reported a disposition of company common stock. On January 27, 2026, a transaction coded "F" involved 2,591 shares of Concentrix common stock at a price of $41.61 per share. Following this transaction, Caldwell beneficially owned 359,430 shares of Concentrix common stock in direct ownership.

Insider Trade Summary

Exercise Price or Tax Liability: 2,591 shares

Exercise Price or Tax Liability 1 txn

Insider Caldwell Christopher A

Role President and CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	2,591	$41.61	$108K

Holdings After Transaction: Common Stock — 359,430 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Concentrix (CNXC) report for January 27, 2026?

Concentrix reported that President and CEO Christopher A. Caldwell disposed of 2,591 shares of common stock on January 27, 2026 in a transaction coded "F" at $41.61 per share, according to the Form 4 filing.

How many Concentrix (CNXC) shares does CEO Christopher A. Caldwell own after this Form 4 transaction?

After the reported transaction, Christopher A. Caldwell beneficially owns 359,430 shares of Concentrix common stock. The filing indicates these shares are held with direct ownership, reflecting his remaining stake following the January 27, 2026 disposition.

What does the transaction code "F" mean in the Concentrix (CNXC) Form 4 filing?

The Form 4 lists the transaction code as "F" for Christopher A. Caldwell’s January 27, 2026 trade. The code is provided in the filing’s transaction table, identifying the nature of the disposition under SEC reporting requirements without further explanation in the excerpt.

What price per share was reported in the latest Concentrix (CNXC) insider transaction?

The reported price per share for Christopher A. Caldwell’s January 27, 2026 transaction was $41.61. This price applies to the 2,591 shares of Concentrix common stock shown as disposed of in the Form 4’s non-derivative securities table.

What role does Christopher A. Caldwell hold at Concentrix (CNXC) in this Form 4?

In this Form 4, Christopher A. Caldwell is identified as both a Director and an Officer of Concentrix, serving as President and CEO. These roles classify him as an insider subject to Section 16 reporting for transactions in company securities.

Is the reported Concentrix (CNXC) insider transaction held directly or indirectly?

The Form 4 states that Christopher A. Caldwell’s beneficially owned 359,430 shares of Concentrix common stock are held with direct (D) ownership. No nature of indirect beneficial ownership is listed in the relevant column for this transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/29/2026 - 04:21 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caldwell Christopher A

(Last) (First) (Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/27/2026		F		2,591	D	$41.61	359,430	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.